ARCHIVES

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

May 28, 2004

In Brief: Eight Site Visits at Prospective Comprehensive Centers Scheduled For NCCAB Members In ’75, 76

July 4, 1975

DRG Reimbursement Schedules Estimated for High, Low Areas; City Of Hope Added to Exemptions, Other Without Much Hope

November 18, 1983

Human Tissue Available Through NCI Network

July 10, 1987

Solomon Gard Loses Final Cancer Battle

February 12, 1982

In Brief: Leonidas Platanias named director of Lurie Comprehensive Cancer Center

October 3, 2014